GET DAILY SIGNALSPalladyne AI Corp (PDYN): Can Shares Reach the $11 Analyst Target?
Key Takeaways
- The central price target of $11 is the arithmetic mean of four verified analyst price targets (a calculated average of $10.75, rounded for clarity), with a low of $7 and a high of $15.
- At a recent price of roughly $3.02, reaching $11 would require an increase of about 264%, a very large move even for a volatile small-cap defense-technology name.
- The strongest supporting factors are accelerating defense-contract momentum, a growing backlog, and strategic partnerships in autonomous and counter-drone systems.
- The biggest risks are widening net losses, ongoing cash burn and potential dilution, high short interest, and recent analyst target reductions.
- You can dig deeper into the company's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages, where readers can explore these areas in more detail.
- For automated, AI-driven market scanning and trade ideas, explore Trending AI Robots.
Analyst Price Targets and Consensus View
Palladyne AI Corp. (NASDAQ: PDYN) is a U.S.-based defense and industrial technology company developing embodied artificial-intelligence software and collaborative autonomy solutions for robotics, drones, and aerospace applications. It is covered by four analysts whose targets remain well above the current share price.
As of the most recent updates, the four verified targets are: Lake Street at $11 (Buy, September 15, 2026), Northland Securities at $15 (Buy, August 7, 2026), Alliance Global Partners at $10, lowered from $12 (Buy, August 6, 2026), and Jefferies at $7, lowered from $8 (Hold, May 6, 2026). The arithmetic mean of these four figures is $10.75, which rounds to the $11 central target used throughout this article. The full range spans $7 to $15, reflecting a wide divergence of opinion.
Three of four analysts carry Buy ratings and one a Hold, producing a broadly constructive but not unanimous stance. The bullish view rests on defense-autonomy demand, an exclusive U.S. manufacturing role for Israel Aerospace Industries' loitering-munition systems, and expanding contract awards. The more cautious view, reflected in Jefferies' Hold and the two recent target cuts, emphasizes that profitability remains distant and that the company is still burning cash. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path Toward the Target
The stock closed near $3.02 on November 6, 2026, down sharply from a 52-week high of $10.00 reached in March 2026 and within roughly 14% of its 52-week low of $2.66. Reaching the $11 target would require an upside of approximately 264%, which is a very large move and would take the shares back above their prior peak.
The potential path is tied less to near-term valuation than to execution. Palladyne AI reported second-quarter fiscal 2026 revenue of about $5.8 million, up roughly 470% year over year, alongside a widened net loss of about $12.3 million and an EPS (earnings per share) loss of $0.27. Management has reiterated fiscal 2026 revenue guidance of $24 million to $27 million and cited a backlog of roughly $24 million. Converting that backlog and pipeline into sustained, higher-margin revenue is the central question for whether the stock can meaningfully re-rate.
What Could Support a Move Toward the Target
Several verified developments underpin the constructive case. The company has announced a string of defense-related milestones, including a joint-development program for the SwarmShot counter-drone system with Federal Ammunition and Mossberg, selection of its BRAIN edge-AI flight computer as a finalist in a U.S. Army competition, a U.S. Air Force contract expansion, and a U.S. Navy-related subsidiary award for low-cost near-hypersonic missile development. Partnerships with Red Cat, FANUC America, and NORDA Dynamics broaden its addressable markets across drones and industrial robotics. Analysts who maintain Buy ratings generally point to this contract momentum and the potential for larger program awards as reasons for upside.
What Could Prevent the Target From Being Reached
The obstacles are substantial. The company is unprofitable, with trailing-twelve-month revenue near $11.8 million against a net loss of about $30 million, and losses have widened even as revenue grows. Profitability is not expected in the near term, leaving the shares dependent on continued funding and exposing investors to dilution risk. The stock carries a beta near 3.9 and short interest near 15% of float, indicating elevated volatility and skepticism. Recent downward revisions by Jefferies and Alliance Global Partners show that analysts themselves have tempered near-term expectations, and the shares' roughly 70% decline from their March 2026 high underscores how quickly sentiment can shift.
Technical Levels and Market Structure
The technical picture remains bearish. The stock trades below its shorter- and longer-term moving averages, and the recent $2.66 low is a key support level that, if broken, would mark a fresh multi-year trough. On the upside, the shares face layered resistance near the $5 and $7 zones before any approach toward the prior $10 high, which also acts as a psychological round-number level. The wide gap between the current price and the $10 to $15 range of analyst targets highlights how far the stock would need to travel to validate those objectives.
Time Horizon and What Investors Should Monitor
Analyst price targets typically reflect a research horizon of around 12 months, though firms do not always publish a precise time frame, and the wide $7 to $15 range signals meaningful disagreement. The most important near-term event is the third-quarter fiscal 2026 earnings report scheduled for November 10, 2026, along with any update to full-year guidance. Investors should also watch backlog conversion, new contract awards, cash burn and any capital raises, analyst target revisions, and broader defense-sector sentiment. No definitive timing should be assumed. From what I see, keeping an eye on these catalysts is essential for any position in this name.
AI Daily Buy/Sell Signals
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis evolve. Rather than replacing research, the tool is designed to help traders discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual review alone. For a volatile, news-driven name like Palladyne AI, such automated signals can offer a useful complement to fundamental and technical work, and traders can explore the platform to see how these signals apply to their own watchlists.
Final Assessment
The $11 central target is the rounded arithmetic mean of four verified analyst price targets, and it sits far above a recent share price near $3.02, implying a very large required move of roughly 264%. The supporting case rests on genuine momentum in defense contracts, a growing backlog, and strategic partnerships, while the counterweights are widening losses, cash burn, dilution risk, high short interest, and recent analyst target cuts. The wide $7-to-$15 analyst range reflects genuine uncertainty about how quickly, if at all, the company can convert its autonomy pipeline into durable profitability. Whether the shares can reach $11 will depend on execution, funding discipline, and sustained defense-demand momentum rather than on the target itself, and no outcome is guaranteed.
Exploring AI Tools for Deeper Analysis
In my own process, I often turn to Tickeron’s AI tools to scan for patterns and signals across similar small-cap names. The platform’s AI Daily Buy/Sell Signals and related features help surface ideas that complement traditional research, especially when evaluating names with high volatility like this one. It is a practical way to stay organized without replacing core due diligence.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
PDYN's RSI Indicator ascends from oversold territory
The RSI Indicator for PDYN moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 27 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for PDYN just turned positive on November 09, 2026. Looking at past instances where PDYN's MACD turned positive, the stock continued to rise in 46 of 52 cases over the following month. The odds of a continued upward trend are 88%.
Following a +30.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where PDYN advanced for three days, in 203 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
PDYN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PDYN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for PDYN entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.103) is normal, around the industry mean (16.272). P/E Ratio (-4.254) is within average values for comparable stocks, (52.956). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.430) among similar stocks. P/S Ratio (21.413) is also within normal values, averaging (103.889).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. PDYN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PDYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ComputerCommunications
Advertisement